Press Release November 18, 2021NVAX Stock Alert: 2 Big Reasons Novavax Shares Are Climbing Today 0 0 Share
Press Release November 18, 2021SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 0 0 Share
Press Release November 18, 2021Novavax Shares Are Rising On Incremental COVID-19 Vaccine Related News 0 0 Share
Press Release November 18, 2021Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Novavax, Inc. (NVAX) Investors 0 0 Share
Press Release November 18, 2021Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc. 0 0 Share
Press Release November 18, 2021NOVAVAX SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX 0 0 Share
Press Release November 18, 2021NOVAVAX, INC. (NASDAQ: NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Novavax, Inc. 0 0 Share
Press Release November 18, 2021NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders 0 0 Share
Press Release November 17, 2021Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines 0 0 Share
